Apex Biotechnology Corp. · TWSE:1733

Apex Biotechnology — Investor Conference (May 2023)

15 slides from Apex Biotechnology's conference presentation, May 25, 2023

  1. Slide 1: ApexBio Investor Conference May 2023

    BES 2k APEXBIO aitiwan May 2023

  2. Slide 2: Company profile

    Company profile TSEC 1733 Industry IVD Medical Device Operation Locations .Head quarter: No. 7, Li-Hsin 5th Rd., Hsinchu Science Park, Hsinchu, Taiwan .Tao Yuan Factory: No. 180, Lane 70, Wuqing Rd., Dayuan Dist., Taoyuan City, Taiwan .Suzhou Corp.: Room 106, No.2, Kecheng Road, SIP, Suzhou, China .

  3. Slide 3: Milestone

    Milestone 1997-2001 2002-2006 2007-2011 1997 ApexBio set-up 2002 ISO 9001/13485 notified 2007 Lactate launch 1998 BGM FDA 510K approval 2003 CE IVDD notified 2008 oice BGM launch 1999 Uric Acid patent granted 2005 Pesticide residues check 2009 Taoyuan factory set-up 2000 IPO listed to Taiwan OTC pro

  4. Slide 4: Quality System

    Quality System Region The Authority Regulatory compliance Taiwan TFDA GMP ISO 13485:2016 EU CE CE mark number:CE0197 EN ISO 15197:2015 510K’s FDA on-site audit w/o 483 USA FDA citations 2001/2006/2011/2016 China CFDA Medical Device Class II Japan PMDA Brazil ANVISA 2017 passed on-site audit

  5. Slide 5: Product profile

    Product profile Blood glucose monitoring systems Professional Monitoring systems  Uric Acid  Hemoglobin  Lactate  Ketone  HbA1C 5

  6. Slide 6: Multi-functional systems

    Multi-functional systems  Glucose+Uric Acid  Glucose+Ketone  Glucose+Cholesterol  Glucose+Cholesterol+TG+Uric Acid 6

  7. Slide 7: GLUCOSURE POC

    Ketone POC barcode scanner + wifi (EU territory distributed by Roche ) 醫院專用 GLUCOSURE POC Glucose/Ketone POC barcode scanner + wifi 7

  8. Slide 8: Eclipse PLUS

    Eclipse PLUS For Clinic and Hospital Pre-screening Diabetic Kidney Disease • 糖化血色素(HbA1c) • 微量白蛋白(Microalbumin) • 肌酸酐(Creatinine) • 微量白蛋白/肌酸酐比值(ACR)

  9. Slide 9: New pipeline products

    New pipeline products  Rapid test TFDA QMS passed Developing items: • COVID-19 Antigen Rapid Test Kit • Influenza Rapid Test Kit • Vector-borne Disease Detection for Mosquito-borne Illnesses • Economic Animal and Animal Epidemic Prevention Detection  Home use CGM  Smart POC

  10. Slide 10: Customized projects

    Customized projects  Product platform focus on electrochemistry/photometry/ Lateral flow assay , to derive new parameter tests and optimize our core platform.  Sharing our advantage of regulation/quality control/sales channels/clinical trails/manufacturing to alliance with partners and customers.

  11. Slide 11: Global sales distribution

    Global sales distribution Territory 2021 2022 2023/1Q America 43% 40% 32% EU 45% 49% 55% Asia 11% 10% 13% Africa 1% 1% 0%

  12. Slide 12: Finance Performance

    Finance Performance 2021 2022 2023/1Q Revenue 2,131,656 2,244,176 436,537 Gross margin 571,512 576,839 134,216 Operation profit 204,949 176,560 42,053 Profit after tax 202,289 181,451 35,748 EPS 2.03 1.82 0.36 G/M ratio 27% 26% 31% Shipped Meter Qty 1,677K 1,821K 276K (kit) Shipped Strip 1,167M 1,11

  13. Slide 13: Product ratio 2023/1Q

    Product ratio 2022 2023/1Q BGM & A1C Electrode BGM & A1C Electrode Non-BGM Others Non-BGM Others 3% 3% 14% 15% 13% 14% 70% 68% Non-BGM Hemoglobin/Ketone/UricAcid/Lactate/Cholesterol/ Pesticide quick check etc

  14. Slide 14: The 9th Corporate Governance Evaluation (2022)

    the 9th Corporate Governance Evaluation (2022) Number of Points for Total number of inapplicable Extra Credit Category weighting satisfied indicators indicators Indicators: indicators Year 2021 2022 2021 2022 2021 2022 2021 2022 2021 2022 Protecting Shareholder Rights and Interests 16 16 0.2 0.2 15

  15. Slide 15: Thank you

    Thank you

Apex Biotechnology — Investor Conference (May 2023) on 6ix